Sanofi (SNY) reported Q1 earnings Thursday of 1.79 euros ($2.04) per share, up from 1.53 euros a year earlier.
Revenue for the quarter ended March 31 was 9.90 billion euros, compared with 8.93 billion euros a year earlier.
Analysts polled by FactSet expected 9.95 billion euros.
The company reaffirmed its 2025 business EPS guidance of a low double-digit percentage growth at current exchange rate. It also maintained sales guidance to grow by a mid-to-high single-digit percentage at current exchange rate. Analysts polled by FactSet expect 44.97 billion euros.